9 Meters Biopharma, Inc.

NMTRQ

US6544052086

Investment Holding Companies

Market Closed - OTC Markets Other stock markets 09:33:58 2024-07-08 am EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

Mar. 25	North American Morning Briefing : Tech in Focus on -2-	DJ
2023	Bidding Procedure Approved for 9 Meters Biopharma, Inc.	CI

Innovate Biopharmaceuticals, Inc. Terminates June S. Almenoff as Chief Operating Officer and Chief Medical Officer

November 23, 2018 at 05:14 pm EST

The employment of June S. Almenoff, M.D., Ph.D., F.A.C.P., Chief Operating Officer and Chief Medical Officer of Innovate Biopharmaceuticals, Inc. (the “Company”), terminated on November 16, 2018.

Latest news about 9 Meters Biopharma, Inc.

North American Morning Briefing : Tech in Focus on -2-	Mar. 25	DJ
Bidding Procedure Approved for 9 Meters Biopharma, Inc.	Nov. 28	CI
Amendment to Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	Nov. 26	CI
Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	Nov. 06	CI
North American Morning Briefing : Stocks Look to -2-	Nov. 06	DJ
Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	Nov. 02	CI
North American Morning Briefing : Stock Futures -2-	23-09-22	DJ
North American Morning Briefing : Mood Seen Buoyed -2-	23-09-15	DJ
North American Morning Briefing : Apple's China Conflict, Rate Hike Fears Continue to Weigh	23-09-08	DJ
North American Morning Briefing : Jobs Report Eyed for Hiring Slowdown	23-09-01	DJ
North American Morning Briefing : Investors Await Powell's Jackson Hole Speech	23-08-25	DJ
North American Morning Briefing : China Trouble Hits Sentiment	23-08-18	DJ
North American Morning Briefing : Stock Futures -2-	23-08-11	DJ
Illumina cuts annual profit forecast as biotech funding woes linger	23-08-09	RE
Illumina cuts annual profit forecast	23-08-09	RE
9 Meters Biopharma, Inc.(OTCPK:NMTR.Q) dropped from NASDAQ Composite Index	23-07-25	CI
9 Meters Biopharma, Inc.(NasdaqCM:NMTR) dropped from S&P TMI Index	23-07-21	CI
Drug developer 9 Meters Biopharma files for bankruptcy protection	23-07-18	RE
9 Meters Biopharma, Inc. Filed for Bankruptcy	23-07-17	CI
9 Meters Biopharma Names Bethany Sensenig Interim Chief Executive; Shares Fall	23-05-30	MT
9 Meters Biopharma, Inc. Provides Clinical Update on Vurolenatide in Patients with Short Bowel Syndrome	23-05-30	CI
9 Meters Biopharma, Inc. Announces the Resignation of John Temperato as President	23-05-30	CI
9 Meters Biopharma, Inc. Announces the Resignation of John Temperato as Chief Executive Officer	23-05-30	CI
9 Meters Biopharma, Inc. Appoints Bethany Sensenig as Interim CEO	23-05-29	CI
Citigroup Adjusts 9 Meters Biopharma Price Target to $0.75 From $1.70, Maintains Neutral Rating	23-05-18	MT

Chart 9 Meters Biopharma, Inc.

Duration

Period

More charts

9 Meters Biopharma, Inc. has ceased operations. The Company has filed a voluntary petition for relief under provisions of Chapter 7 of Title 11 of the United States Code (the Bankruptcy Code) in the United States Bankruptcy Court for the Eastern District of North Carolina.

Sector

Investment Holding Companies

More about the company

Income Statement Evolution

More financial data

Quarterly earnings - Rate of surprise

Company calendar

Sector Shell Companies

	1st Jan change	Capi.
9 METERS BIOPHARMA, INC.	0.00%	14
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+76.43%	5.87B
CHURCHILL CAPITAL CORP VII	+2.76%	988M
PERELLA WEINBERG PARTNERS	+46.03%	955M
ARES ACQUISITION CORPORATION II	+2.49%	669M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
E7 GROUP	-2.15%	593M
ADMIRAL ACQUISITION LIMITED	+10.28%	536M
CAPITOL INVESTMENT CORP. VII	-.--%	500M
AEA-BRIDGES IMPACT CORP.	-2.10%	470M

Shell Companies

9 Meters Biopharma, Inc.

Equities

NMTRQ

US6544052086

Investment Holding Companies

Innovate Biopharmaceuticals, Inc. Terminates June S. Almenoff as Chief Operating Officer and Chief Medical Officer

Latest news about 9 Meters Biopharma, Inc.

Chart 9 Meters Biopharma, Inc.

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Shell Companies